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concentrations of renin were too high to be explained by admixture of blood. This raises the possibility of an intraocular RAS, independent of the RAS in the circulation.
Methods-In the present study, gene expression of RAS components in different parts of enucleated human eyes was investigated as evidence for tissue specific production. Results-By using pooled tissue samples renin mRNA could be detected with the RNAse protection assay in retinal pigment epithelium (RPE) choroid, but not in neural retina or sclera. With reverse transcription polymerase chain reaction (RT-PCR), renin mRNA was detected in individual samples of RPE choroid and neural retina, and not anterior uveal tract or sclera. Angiotensinogen and angiotensin converting enzyme (ACE) gene expression could be demonstrated by RT-PCR in individual RPE choroid and neural retina samples and marginally in sclera samples. Conclusion-These results support the concept of intraocular synthesis of angiotensin II, independent of renin, angiotensinogen, and ACE in the circulation. Since gene expression was highest in ocular parts, which are highly vascularised, local angiotensin II may be involved in blood supply and/or pathological vascular processes such as neovascularisation in diabetic retinopathy. (BrJ Ophthalmol 1996; 80: 159-163) The renin-angiotensin system (RAS) plays an important role in the control of blood pressure and electrolyte homeostasis. The enzyme renin cleaves its substrate, angiotensinogen, to form angiotensin I. Angiotensin I is then converted by angiotensin converting enzyme (ACE) to angiotensin II, a potent vasoconstrictor and a stimulant of aldosterone release.
Components of the RAS are present both in the circulating blood and in tissues, including the eye. 1-7 Their presence in the eye cannot be explained by admixture with blood,' 2 7 suggesting that a local, intraocular, RAS may exist. Expression of RAS component genes in specific ocular tissues, however, has not been demonstrated so far. In a variety of other tissues -for example, adrenal, placenta, gonads, and brain, such expression has now been detected,8-'0 thereby raising the possibility of local production of angiotensin II independent of the circulating RAS. " 1 12 The function of a local RAS in the eye is unknown. Angiotensin II receptors have been detected in retinal blood vessels, suggesting that angiotensin II may be involved in the regulation of retinal vascular tone.'3 14 Apart from a role in the control of ocular perfusion, angiotensin II may also affect the regulation of aqueous fluid haemodynamics, since local application of ACE inhibitors lowers intraocular pressure.'5 The RAS has also been implicated in diseases of the eye. High levels of prorenin, the inactive precursor of renin, have been found in plasma of diabetic subjects and these high levels correlated with the presence of microvascular complications, proliferative retinopathy in particular.'6 17 Moreover, vitreous fluid obtained during eye surgery from diabetic patients with proliferative retinopathy contained higher levels of prorenin than vitreous obtained from non-diabetic subjects without retinopathy,' suggesting that the intraocular RAS may be activated in diabetic subjects with proliferative retinopathy.
In pooled tissue samples, because it was not sensitive enough to detect renin-mRNA in individual eye samples. Examination of individual eye samples was possible only by using PCR. Human kidney samples served as positive controls, since in these samples renin mRNA, angiotensinogen mRNA, and ACE mRNA are readily detectable.1I
Using the RNAse protection assay, renin mRNA expression could be demonstrated in pooled RPE choroid samples, which also contained some neural retinal tissue, but not in neural retina alone or in sclera (Fig 1) . Compared with the kidney, the ocular renin mRNA levels were low (Fig 1) .
protection assay was used in The length of the PCR products of the different genes detected in the eye were identical to the corresponding amplification signal from the kidney (Figs 2-4) . After reverse transcription of 1 ,ug of total RNA and subsequent amplification, all three components of the RAS could be detected in both neural retina and RPE choroid.
Repeatedly, renin mRNA expression appeared to be higher in RPE choroid than in retina alone (Fig 2) , confirming our findings with the RNAse protection assay, where renin mRNA was detected in RPE choroid but not neural retina. RPE choroid renin mRNA expression was similar in samples from eyes enucleated for choroidal melanoma and eyes enucleated for other reasons (data not shown). In scleral tissue, either no signal or a signal close to the detection limit for renin gene expression was observed, as was the case in the RNAse protection assay. No positive signal of renin mRNA expression was observed in the two anterior uveal tract samples we studied (data not shown).
Angiotensinogen and ACE gene expression were subjected to PCR analysis only, because of the small amount of human material available. Angiotensinogen and ACE expression were detected both in RPE choroid and neural retina (Figs 3 and 4) . No marked differences were found between these two ocular tissues in the expression of either angiotensinogen or ACE. At the end of PCR amplification, expression of these two RAS components was absent or only marginal in sclera (data not shown).
Discussion
This study demonstrates gene expression of renin, angiotensinogen, and ACE in various parts of the human eye. These peptides may therefore be synthesised locally within the eye. These data, together with previous findings demonstrating the presence of RAS components in human and cattle ocular fluids and tissues,1-7 strongly support the existence of an intraocular RAS independent of the circulating RAS. Renin gene expression was found to be highest in the RPE choroidal layer, both by RNAse protection assay and by polymerase chain reaction. Using the polymerase chain reaction, renin mRNA could also be detected in the neural retina. The polymerase chain reaction only gives a rough measure of gene expression. However, in view of the results obtained with the RNAse protection assay, expression of the renin gene is most likely lower in the neural retina than in the RPE choroid. In support of this assumption, the ocular renin and angiotensin levels were found to be lower in the retina than in the RPE choroid. 27 In human eyes, prorenin, the inactive precursor of renin, has been detected in aqueous, vitreous, and subretinal fluid, the highest levels being present in the latter.' Based upon these findings and the present study, one may speculate about the source of prorenin in human ocular fluids. As we have shown previously, prorenin leakage from plasma is only a minor source of ocular fluid prorenin.' Prorenin produced in the retina can directly enter the vitreous fluid, whereas prorenin synthesised in the choroid would first have to pass the RPE. This layer is part of the so called 'blood-retinal barrier', which is normally impermeable to proteins such as prorenin. Under pathophysiological conditions -for instance, in eyes affected by proliferative retinopathy in diabetic subjects,25 partial breakdown of the bloodretinal barrier may occur, so that this barrier becomes permeable to prorenin.
Two lines of evidence support prorenin production in the posterior part (retina and/or RPE choroid) of the eye. Firstly, as mentioned above, prorenin levels were higher in vitreous than in aqueous.1 Secondly, a prorenin gradient exists in vitreous fluid with the lowest levels present in the most anterior parts of the vitreous.2 Others have suggested that ocular prorenin is produced in the anterior uveal tract,3 since they detected prorenin by immunohistochemistry in the pars plicata of the ciliary body. We also detected renin and prorenin in the anterior uveal tract (ciliary body and iris) of the bovine eye.2 However, in the present study we failed to show renin mRNA expression in this part of the eye. RPE choroid and retina, therefore, are the most likely production sites of (pro)renin in the eye.
It has not been clarified yet, whether (pro)renin at these sites is expressed in the vasculature ( 
